The American Diabetes Association has transitioned the June 12-16, 2020 Scientific Sessions from a live, in-person meeting to a virtual meeting. This 5-day virtual event will bring the latest, cutting-edge advances in diabetes research, prevention, and care and include a virtual Poster Hall, virtual Exhibit Hall, and virtual receptions. For your convenience, we’ve compiled a list of our virtual ADA presentations.
Abstract 928-P | Dulaglutide Has Higher Adherence and Persistence than Semaglutide and Exenatide QW: 6-Month Follow-Up from U.S. Real-World Data
Mody R1, Yu M1, Nepal B2, Konig M1, Grabner M2
1Eli Lilly, Indianapolis, IN, 2HealthCore, Inc., Wilmington, DE
Abstract 929-P | Dulaglutide Shows Sustained A1C Reduction: Two-Year U.S. Real-World Study
Mody R1, Yu M1, Grabner M2, Boye K1, Teng CC2, Kwan A1
1Eli Lilly, Indianapolis, IN, 2HealthCore, Inc., Wilmington, DE
Abstract 953-P | Real-World Effectiveness of Once-Weekly Semaglutide from a U.S. Commercially Insured and Medicare Advantage Population
Visaria J1, Uzoigwe C2, Swift C2, Paprocki Y2, Willey V1
1HealthCore, Inc., Wilmington, DE, 2Novo Nordisk, Plainsboro Township, NJ
View all HealthCore presentations at professional.diabetes.org.